Please use this identifier to cite or link to this item:
|Title:||Theranostic liposomes for cancer diagnosis and treatment: Current development and pre-clinical success||Authors:||Muthu, M.S.
Vitamin E TPGS
|Issue Date:||Feb-2013||Citation:||Muthu, M.S., Feng, S.-S. (2013-02). Theranostic liposomes for cancer diagnosis and treatment: Current development and pre-clinical success. Expert Opinion on Drug Delivery 10 (2) : 151-155. ScholarBank@NUS Repository.||Abstract:||Liposomes are one of the effective drug delivery systems that are developed based on the nanotechnology concept. Liposomal formulation is the first nanomedicine approved by the US FDA for clinical application. Recently, the marketed liposomes and stealth liposomes have made impact for cancer therapy. In addition, a few receptor-targeted liposome products have been in different phases of clinical trials, which are yet to be marketed. In the present editorial, the advantages of vitamin E TPGS-coated liposomes over the currently available PEG-coated liposomes will be described and their great potentials for nanotheranostics for cancer imaging and therapy will be covered. © 2013 Informa UK, Ltd.||Source Title:||Expert Opinion on Drug Delivery||URI:||http://scholarbank.nus.edu.sg/handle/10635/68446||ISSN:||17425247|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 26, 2018
WEB OF SCIENCETM
checked on Dec 26, 2018
checked on Sep 16, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.